 | | Vol. 14.37 – 29 September, 2023 |
| |
|
|
| Researchers demonstrated that the DNA-PK holoenzyme was part of the androgen receptor variant 7 (AR-V7) interactome and was a key regulator of AR-V-mediated transcription and cell growth in models of advanced prostate cancer.
[Journal of Clinical Investigation] |
|
|
|
 | | PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The combination of smart nanocarrier and sequential ‘405-580 nm’ irradiation strategy exhibited good photodynamic therapy efficacy against 2D 22RV1 prostate cancer cells as well as 3D cancer cell spheroids.
[Acta Biomaterialia] |
|
|
|
| Using shRNA-mediated PDE4D7 knockdown in LNCaP cells, scientists replicated clinical observations that diminished PDE4D7 expression promoted an aggressive prostate cancer phenotype.
[British Journal of Cancer] |
|
|
|
| Investigators found that circular RNA DDIT4 (circDDIT4) was downregulated in prostate cancer and functioned as a tumor suppressor during prostate cancer progression.
[Molecular Cancer Research] |
|
|
|
| Microfibrillar matrices were fabricated as 3D spherical and disc-shaped scaffolds with highly interconnected pores and the potential of the newly developed scaffolds for developing prostate cancer model has been investigated.
[Biomedical Materials] |
|
|
|
| Polyphyllin I (PPI), one of the steroidal saponins in paris polyphylla, has been shown to have an anticancer effect. Researchers investigated the role and mechanism of PPI in CRPC cell ferroptosis.
[The Prostate] |
|
|
|
| The authors investigated the effectiveness and molecular characteristics of docetaxel and radiation combination therapy in vitro.
[International Journal of Radiation Biology] |
|
|
|
| Investigators detected the toxicity of sennoside A (SA) on PC3 and DU 145 cells via CCK-8. The effects of SA on growth, apoptosis, and autophagy were determined through additional examinations.
[Journal of Molecular Histology] |
|
|
|
| To investigate the molecular mechanisms underlying the effects of nimotuzumab on prostate cancer development, the authors focused on the miR-199a-5p and miR-214-3p miRNA clusters.
[Kaohsiung Journal Of Medical Sciences] |
|
|
|
|
| Scientists discuss how expression of the splicing regulators ESRP1 and ESRP2, and how their role as “masterminds” of epithelial splicing patterns, have been identified as markers of aggressively proliferating prostate primary tumors.
[Oncogene] |
|
|
|
|
| Profound Medical Corp. announced that it has received 510(k) clearance from the US FDA for the Company’s Thermal Boost module for use in conjunction with TULSA-PRO®.
[Profound Medical Corp. (Globe Newswire)] |
|
|
|
|
| November 7 – 8, 2023
London, England, United Kingdom |
|
|
|
|
|
| | Cancer Research UK Manchester Institute – Manchester, England, United Kingdom |
|
|
|
| | Cedars-Sinai – Los Angeles, California, United States |
|
|
|
| | Massachusetts General Hospital – Boston, Massachusetts, United States |
|
|
|
| | Houston Methodist Research Institute – Houston, Texas, United States |
|
|
|
| | The Sidney Kimmel Cancer Center – Philadelphia, Pennsylvania, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
